OC
MDCO

Oppenheimer & Co’s Medicines Co MDCO Stock Holding History

Oppenheimer & Co’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-8,811
Closed -$247K – 1587
2015
Q1 		$247K Buy
+8,811
New +$247K 0.01% 1188
2013
Q4 		– Sell
-8,309
Closed -$279K – 1473
2013
Q3 		$279K Sell
8,309
-26,601
-76% -$847K 0.01% 1004
2013
Q2 		$1.07M Buy
+34,910
New +$1.17M 0.04% 497

Other funds holding MDCO

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CM
Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Oppenheimer & Co's MDCO Position: Q2 2015 in Review

Oppenheimer & Co sold out of Medicines Co (MDCO) in Q2 2015, closing a stake of 8,811 shares — an estimated $247K sold.

Oppenheimer & Co first reported a position in MDCO in Q2 2013 and held it in 3 quarters. The position peaked at $1.07M in Q2 2013. 172 funds tracked by Wall St. Rank hold MDCO as of Q2 2015.

  • Oppenheimer & Co reported no remaining Medicines Co position as of Q2 2015 after selling out during the quarter.
  • Oppenheimer & Co sold 8,811 Medicines Co shares in Q2 2015, an estimated $247K.
  • Oppenheimer & Co first reported a position in Medicines Co in Q2 2013 and held it in 3 quarters.
  • Oppenheimer & Co's Medicines Co position peaked at $1.07M in Q2 2013.
  • 172 funds tracked by Wall St. Rank held Medicines Co as of Q2 2015.

Based on Oppenheimer & Co's 13F filing for Q2 2015, filed 12 Aug 2015.